BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15371946)

  • 21. Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules.
    Provenza C; Young RH; Prat J
    Am J Surg Pathol; 2008 Mar; 32(3):383-9. PubMed ID: 18300813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
    Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
    Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian mucinous carcinoids including some with a carcinomatous component: a report of 17 cases.
    Baker PM; Oliva E; Young RH; Talerman A; Scully RE
    Am J Surg Pathol; 2001 May; 25(5):557-68. PubMed ID: 11342766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic problems of ovarian mucinous borderline tumors].
    Vereczkey I; Tóth E; Orosz Z
    Magy Onkol; 2009 Jun; 53(2):127-33. PubMed ID: 19581178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucinous borderline ovarian tumors: pathological and prognostic study at Salah Azaiez Institute.
    Sahraoui G; Fitouri A; Charfi L; Driss M; Slimane M; Hechiche M; Mrad K; Doghri R
    Pan Afr Med J; 2022; 41():349. PubMed ID: 35909430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benign, borderline, and well-differentiated malignant intestinal mucinous tumors of the ovary: a clinicopathologic, histochemical, immunohistochemical, and nuclear quantitative study of 57 cases.
    de Nictolis M; Montironi R; Tommasoni S; Valli M; Pisani E; Fabris G; Prat J
    Int J Gynecol Pathol; 1994 Jan; 13(1):10-21. PubMed ID: 8112952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Borderline ovarian tumours: retrospective analysis of twenty-one cases.
    Saygili U; Uslu T; Erten O; Doğan E
    Eur J Gynaecol Oncol; 1998; 19(2):182-5. PubMed ID: 9611063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
    Vasconcelos I; Darb-Esfahani S; Sehouli J
    BJOG; 2016 Mar; 123(4):498-508. PubMed ID: 26705090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.
    Taylor J; McCluggage WG
    Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma).
    Koskas M; Uzan C; Gouy S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
    Ann Surg Oncol; 2011 Jan; 18(1):40-8. PubMed ID: 20737216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucinous carcinoma of the ovary. Clinicopathologic analysis.
    Kikkawa F; Kawai M; Tamakoshi K; Suganuma N; Nakashima N; Furuhashi Y; Kuzuya K; Hattori S; Arii Y; Tomoda Y
    Oncology; 1996; 53(4):303-7. PubMed ID: 8692534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IMP3 Expression in Borderline Tumors of the Ovary.
    El-Balat A; Sänger N; Karn T; Becker S; Holtrich U; Muallem Z; Arsenic R
    Anticancer Res; 2017 Feb; 37(2):583-588. PubMed ID: 28179304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mucinous ovarian neoplasms. Prognostically mostly excellent, infrequently a wolf in sheep's clothing].
    Lax S; Staebler A
    Pathologe; 2014 Jul; 35(4):327-35. PubMed ID: 24962632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion.
    Prat J; De Nictolis M
    Am J Surg Pathol; 2002 Sep; 26(9):1111-28. PubMed ID: 12218568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocervical-like versus intestinal-type mucinous borderline ovarian tumors: a large retrospective series focusing on the clinicopathologic characteristics.
    Song T; Choi CH; Lee YY; Kim TJ; Lee JW; Sung CO; Song SY; Bae DS; Kim BG
    Gynecol Obstet Invest; 2013; 76(4):241-7. PubMed ID: 24192519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucinous borderline ovarian tumors with and without Intraepithelial Carcinoma: Differences in clinicopathologic features and fertility results.
    Chen RF; Tao X; Wu BB; Li J; Wang JY; Gu WY; Lu X
    J Obstet Gynaecol Res; 2020 Apr; 46(4):646-653. PubMed ID: 32045956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Some opinions for intraepithelial neoplasia in female genital duct].
    Zhou XR
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):11-4. PubMed ID: 21429427
    [No Abstract]   [Full Text] [Related]  

  • 39. Primary mucinous tumors of the testis and paratestis: a report of nine cases.
    Ulbright TM; Young RH
    Am J Surg Pathol; 2003 Sep; 27(9):1221-8. PubMed ID: 12960806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocervical carcinoma: a study of 23 patients with clinical-pathological correlation.
    Deligdisch L; Escay-Martinez E; Cohen CJ
    Gynecol Oncol; 1984 Jul; 18(3):326-33. PubMed ID: 6086469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.